63672-0
Did giving up or greatly reducing important activities while using this drug, happen 3 or more times or more or for a month or more [SSAGA II]
Active
Reference Information
| Type | Source | Reference |
|---|---|---|
| Citation | Regenstrief LOINC | Bucholz, Kathleen K., et al. "A new, semi-structured psychiatric interview for use in genetic linkage studies: a report on the reliability of the SSAGA." Journal of studies on alcohol 55.2 (1994): 149-158. |
LOINC Names Get Info
- Fully-Specified Name
- Did giving up or greatly reducing important activities while using this drug, happen 3 or more times or more or for a month or more:
Find: Pt: ^Patient: Ord: SSAGA II - Long Common Name
- Did giving up or greatly reducing important activities while using this drug, happen 3 or more times or more or for a month or more [SSAGA II]
- Short Name
- Reduced activity 3X SSAGA II
Part Model Get Info
- Component
- Did giving up or greatly reducing important activities while using this drug, happen 3 or more times or more or for a month or more
LP114217-5
- Analyte
- Did giving up or greatly reducing important activities while using this drug, happen 3 or more times or more or for a month or more
LP114217-5
- Component Numerator
- Did giving up or greatly reducing important activities while using this drug, happen 3 or more times or more or for a month or more
LP114217-5
- Component Numerator Core
- Did giving up or greatly reducing important activities while using this drug, happen 3 or more times or more or for a month or more
LP114217-5
- Component Numerator Core Suffix
- NULL
- Component Denominator
- NULL
- Component Denominator Core
- NULL
- Component Denominator Core Suffix
- NULL
- Challenge
- NULL
- Adjustment
- NULL
- Count
- NULL
- Property
- Find
LP6813-2
- Time
- Pt
LP6960-1
- Time Core
- Pt
LP6960-1
- Time Modifier
- NULL
- System
- ^Patient
LP310005-6
- System Core
- NULL
- Super System
- Patient
LP6985-8
- Scale
- Ord
LP7751-3
- Method
- SSAGA II
LP241950-7
Survey Question
- Text
- Has this happened 3 or more times, or did it last a month or longer?
- PX031401140201
Normative Answer List: LL1353-3
Source: Consensus measures for Phenotypes and Exposures| Answer | Code | Score | Answer ID |
|---|---|---|---|
| NoCopyright http://snomed.info/sct ID:373067005 No (qualifier value) | 1 | LA32-8 | |
| YesCopyright http://snomed.info/sct ID:373066001 Yes (qualifier value) | 5 | LA33-6 | |
| Don't know/refused | 9 | LA15775-2 |
Basic Attributes
- Class
- PHENX
- Type
- Clinical
- First Released
- Version 2.36
- Last Updated
- Version 2.65 (MIN)
- Change Reason
- Updated Method from PhenX to reflect the original source of the content.; Updated the PhenX ID from "PhenX.<ID>" to "PX<ID>" in Survey Question Source field to align with the variable identifier used in the PhenX Toolkit.
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 62541-8 | PhenX domain - Alcohol, tobacco and other substances |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| el-GR | Greek (Greece) | Η διακοπή ή η σημαντική μείωση σημαντικών δραστηριοτήτων κατά τη χρήση αυτού του ναρκωτικού, συνέβη 3 ή περισσότερες φορές ή για ένα μήνα ή περισσότερο: Synonyms: - A Ord PHENX Pt SSAGA II Ασθενής Εύρεση Η διακοπή ή η σημαντική μείωση σημαντικών δραστηριοτήτων κατά τη χρήση αυτού του ναρκωτικού, συνέβη 3 ή περισσότερες φορές ή για ένα μήνα ή περισσότερο Φάρμακο |
| es-MX | Spanish (Mexico) | Renunció o redujo en gran medida actividades importantes mientras usaba este medicamento, sucedió 3 o más veces o más o durante un mes o más: |
| it-IT | Italian (Italy) | Rinunciare o ridurre notevolmente le attività importanti mentre usava questo farmaco è accaduto 3 o più volte o per un mese o più: Synonyms: Osservazione paziente PhenX Punto nel tempo (episodio) Semi-Structured Assessment For the Genetics of Alcoholism-II |
| zh-CN | Chinese (China) | 使用这种毒品时放弃或大幅度减少重要活动的情况是否发生过3次或更多的次数, Synonyms: Ⅲ A 型 Consensus measures for Phenotypes and eXposures; |
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
Third Party Copyright
This material includes SNOMED Clinical Terms® (SNOMED CT®) which is used by permission of the International Health Terminology Standards Development Organisation (IHTSDO) under license. All rights reserved. SNOMED CT® was originally created by The College of American Pathologists. "SNOMED" and "SNOMED CT" are registered trademarks of the IHTSDO.
This material includes content from the US Edition to SNOMED CT, which is developed and maintained by the U.S. National Library of Medicine and is available to authorized UMLS Metathesaurus Licensees from the UTS Downloads site at https://uts.nlm.nih.gov.
Use of SNOMED CT content is subject to the terms and conditions set forth in the SNOMED CT Affiliate License Agreement. It is the responsibility of those implementing this product to ensure they are appropriately licensed and for more information on the license, including how to register as an Affiliate Licensee, please refer to https://www.snomed.org/get-snomed or [email protected]<mailto:[email protected]>. This may incur a fee in SNOMED International non-Member countries.
LOINC Copyright
Copyright © Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://